Vivesto AB (FRA:OMA) Volatility: 343.64% (As of Jul. 03, 2026)


FRA:OMA Vivesto AB FRA:OMA
33 GF Score
Price €0.70
! 1 Warning Sign
View Full Analysis

What is Vivesto AB Volatility?

Vivesto AB FRA:OMA -1.68% 33 Volatility is 343.64% as of Jul. 03, 2026. GuruFocus rates FRA:OMA with a GF Score™ of 33/100. The stock has 1 warning sign investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-07-03), Vivesto AB's Volatility is 343.64%.


Vivesto AB  (FRA:OMA) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Vivesto AB Volatility Related Terms


FRA:OMA vs ZTS, UTHR, VTRS: Volatility Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vivesto AB's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivesto AB Volatility vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivesto AB's Volatility distribution charts can be found below:

* The bar in red indicates where Vivesto AB's Volatility falls into.


FRA:OMA
33GF Score
Vivesto AB FRA:OMA
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivesto AB  (FRA:OMA) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 343.64% mean?
Vivesto AB (FRA:OMA) has a Volatility of 343.64% as of Jul. 03, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Vivesto AB and its competitors.
Is Vivesto AB's Volatility too high?
Vivesto AB's current Volatility is 343.64%. Overall, Vivesto AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Vivesto AB's Volatility compare to ZTS and UTHR?
Vivesto AB's Volatility of 343.64% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Drug Manufacturers company?
A good Volatility depends on the Drug Manufacturers industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Vivesto AB and its competitors. Vivesto AB's current Volatility is 343.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivesto AB stock overvalued right now?
Vivesto AB (FRA:OMA) has a current Volatility of 343.64%. The current Volatility is 343.64%. Vivesto AB's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Vivesto AB (FRA:OMA), the current Volatility is 343.64% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vivesto AB Business Description

Other Exchanges VIVE:Sweden
Address Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.
33GF Score

Get the complete analysis for FRA:OMA

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.70
Price